FDA — authorised 16 December 2020
- Application: BLA761150
- Marketing authorisation holder: MACROGENICS INC
- Local brand name: MARGENZA
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 MARGENZA in United States
FDA authorised MARGENZA on 16 December 2020
Marketing authorisation
MARGENZA in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is MARGENZA approved in United States?
Yes. FDA authorised it on 16 December 2020.
Who is the marketing authorisation holder for MARGENZA in United States?
MACROGENICS INC holds the US marketing authorisation.